Grace Therapeutics (GRCE) Institutional Ownership $2.70 +0.10 (+3.85%) As of 05/14/2025 03:59 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Grace Therapeutics (NASDAQ:GRCE)CurrentInstitutional OwnershipPercentage6.08%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$671.57KNumber ofInstitutional Sellers(last 12 months)0 Get GRCE Insider Trade Alerts Want to know when executives and insiders are buying or selling Grace Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Grace Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025Stonepine Capital Management LLC294,550$666K0.6%N/A2.905% (Data available from 1/1/2016 forward) GRCE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GRCE shares? During the previous two years, the following institutional investors and hedge funds held shares of Grace Therapeutics shares: Stonepine Capital Management LLC ($666K).Learn more on GRCE's institutional investors. What percentage of Grace Therapeutics stock is owned by institutional investors? 6.08% of Grace Therapeutics stock is owned by institutional investors. Learn more on GRCE's institutional investor holdings. Which institutional investors have been buying Grace Therapeutics stock? The following institutional investors have purchased Grace Therapeutics stock in the last 24 months: Stonepine Capital Management LLC ($294.55K). How much institutional buying is happening at Grace Therapeutics? Institutional investors have bought a total of 294,550 shares in the last 24 months. This purchase volume represents approximately $671.57K in transactions. Related Companies C4 Therapeutics Major Shareholders Genelux Major Shareholders InflaRx Major Shareholders Procaps Group Major Shareholders Silence Therapeutics Major Shareholders BioHarvest Sciences Major Shareholders RAPT Therapeutics Major Shareholders Atossa Therapeutics Major Shareholders Alector Major Shareholders Coya Therapeutics Major Shareholders This page (NASDAQ:GRCE) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRCE Stock Free GRCE Stock Alerts